-
Product Insights
Innovations in Intraocular Lens (IOL) – Global Pipeline Summary
GlobalData's Medical Devices sector report, "Innovations in Intraocular Lens (IOL) - Global Pipeline Summary" provides comprehensive information about the Intraocular Lens (IOL) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Intraocular Lens (IOL) report provides key information and data related to: Extensive coverage of the Intraocular Lens (IOL) under development Review details of major pipeline products which include product description, licensing and collaboration details and other developmental...
-
Innovation Ranking
Innovation Ranking – Lens Technology Co. Ltd.
Lens Technology Co Ltd (Lens), a subsidiary of Lens Technology (Hong Kong) Co Ltd, carries out research, development, manufacturing, and sale of touch-protective glass panels, touch modules, and window-touch materials. The company’s product comprises optical lenses, glass products, metal accessories, TFT-LCD, PDP, OLED, FED flat panel displays, 3D displays and display materials, second-class medical manufacturing equipment, touch switch panels, and modules, and machinery equipment. It markets its products through suppliers. Lens is headquartered in Changsha, Hunan, China.
-
Sector Analysis
Intraocular Lens (IOL) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Intraocular Lens (IOL) Market Report Overview The intraocular lens (IOL) market was valued at $4.48 billion in 2023 and the market will grow at more than 2% during 2023-2033. The rising prevalence of cataracts and refractive error coupled with the increasing population around the globe has compelled governments to start initiatives toward lowering the number of patients suffering from partial or complete blindness. This, in turn, will lead to an increase in the number of eye surgeries and the use...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Selenium Sulfide in Keratoconjunctivitis Sicca (Dry Eye)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Selenium Sulfide in Keratoconjunctivitis Sicca (Dry Eye) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Selenium Sulfide in Keratoconjunctivitis Sicca (Dry Eye) Drug...
-
Product Insights
NewJohnson & Johnson Vision Care Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Johnson & Johnson Vision Care Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Johnson & Johnson Vision Care Inc (J&J Vision Care), a subsidiary of Johnson & Johnson, is a medical device company that manufactures and markets contact lens and spectacle products. The company offers products such as disposable contact lens; contact lenses with astigmatism; contact lenses for presbyopia; contact lenses with hydraclear; and other contact lenses. It also...
-
Product Insights
NewVisioneering Technologies Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Visioneering Technologies Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Visioneering Technologies Inc (VTI) is a medical device company that offers ophthalmic solutions. It develops a portfolio of technologies to address eye care issues such as presbyopia, myopia and astigmatism. VTI offers products such as multifocal lens and sphere lens for presbyope and myopia correction. Its neuro-focus Optics technology, these lenses offer crisp, clear vision at all distances and...
-
Product Insights
Likelihood of Approval Analysis for Ocular Inflammation
Overview How likely is it that the drugs in Ocular Inflammation will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ocular Inflammation Overview Ocular inflammation is an eye inflammation that include choroiditis,...
-
Product Insights
NewBausch & Lomb Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Bausch & Lomb Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Bausch & Lomb Inc (Bausch & Lomb), a subsidiary of Bausch Health Companies Inc, is a vision-care company with focus on the protection, enhancement and restoration of eyesight. It offers over-the-counter supplements, eye care products, contact lenses, ophthalmic pharmaceuticals, lens care products, ophthalmic surgical devices and instruments. The company develops, manufactures and markets eye health products for the...
-
Sector Analysis
Germany Intraocular Lens (IOL) Procedures Count and Forecast to 2030
Germany Intraocular Lens (IOL) Procedures Market Report Overview The total count of Intraocular Lens (IOL) procedures performed in Germany was 1,011,849 in 2022. In these procedures, an artificial lens made of plastic, silicone, acrylic, or some other material is implanted inside the eye during cataract surgery. Germany Intraocular Lens (IOL) Procedures Market Outlook 2022-2030 (Number of Procedures) Buy the Full Report for More Insights on the Germany Intraocular Lens (IOL) Procedures Market Forecast Download a Free Sample Report The Germany...